India to become Russian Sputnik V vaccine’s production hub, to start making 50 mn doses per month by summer
India is the most populous country to approve Sputnik V. India’s medicine regulator Drugs Controller General of India has cleared Russia’s Sputnik V vaccine for emergency use in the country. Sputnik V, made by Moscow’s Gamaleya National Research Institute of Epidemiology and Microbiology, has become the third vaccine after Serum institute of India’s Covishield and Bharat … Read more